Paper41877752
The incidence, clinicopathological characteristics and the survival outcomes among young breast cancer patients in Alexandria, Egypt.
Omar A and 3 others. Ecancermedicalscience, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. The incidence, clinicopathological characteristics and the survival outcomes among young breast cancer patients in Alexandria, Egypt. Papers, record 41877752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41877752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The incidence, clinicopathological characteristics and the survival outcomes among young breast cancer patients in Alexandria, Egypt.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32936216 | Association of Breast Cancer Surgery With Quality of Life and Psychosocial Well-being in Young Breast Cancer Survivors. | JAMA Surg | 2020 | https://conductscience.org/library/papers/32936216 | PubMed |
| 2 | 37668821 | Delayed breast cancer presentation, diagnosis, and treatment in Kenya. | Breast Cancer Res Treat | 2023 | https://conductscience.org/library/papers/37668821 | PubMed |
| 3 | 34278281 | Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns. | EClinicalMedicine | 2021 | https://conductscience.org/library/papers/34278281 | PubMed |
| 4 | 29242041 | Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. | Lancet Oncol | 2018 | https://conductscience.org/library/papers/29242041 | PubMed |
| 5 | 23723422 | Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study. | J Natl Cancer Inst | 2013 | https://conductscience.org/library/papers/23723422 | PubMed |
| 6 | 19505913 | Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in Asia. | Cancer Epidemiol Biomarkers Prev | 2009 | https://conductscience.org/library/papers/19505913 | PubMed |
| 7 | 28894168 | The association of young age with local recurrence in women with early-stage breast cancer after breast-conserving therapy: a meta-analysis. | Sci Rep | 2017 | https://conductscience.org/library/papers/28894168 | PubMed |
| 8 | 28542677 | Association of Previous Clinical Breast Examination With Reduced Delays and Earlier-Stage Breast Cancer Diagnosis Among Women in Peru. | JAMA Oncol | 2017 | https://conductscience.org/library/papers/28542677 | PubMed |
| 9 | 34253800 | Differences in clinicopathological characteristics, treatment, and survival outcomes between older and younger breast cancer patients. | Sci Rep | 2021 | https://conductscience.org/library/papers/34253800 | PubMed |
| 10 | 31157962 | Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31157962 | PubMed |
| 11 | 27771499 | Breast cancer in women aging 35 years old and younger: The Egyptian National Cancer Institute (NCI) experience. | Breast | 2017 | https://conductscience.org/library/papers/27771499 | PubMed |
| 12 | 32178489 | Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017. | Cancer Res Treat | 2020 | https://conductscience.org/library/papers/32178489 | PubMed |
| 13 | 28549339 | Typical and atypical presenting symptoms of breast cancer and their associations with diagnostic intervals: Evidence from a national audit of cancer diagnosis. | Cancer Epidemiol | 2017 | https://conductscience.org/library/papers/28549339 | PubMed |
| 14 | 33150547 | Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer. | Breast Cancer Res Treat | 2021 | https://conductscience.org/library/papers/33150547 | PubMed |
| 15 | 29738005 | Age distribution and outcomes in patients undergoing breast cancer resection in Saudi Arabia. A single-institute study. | Saudi Med J | 2018 | https://conductscience.org/library/papers/29738005 | PubMed |
| 16 | 31618131 | Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT. | J Clin Oncol | 2020 | https://conductscience.org/library/papers/31618131 | PubMed |
| 17 | 25436920 | Biology of breast cancer in young women. | Breast Cancer Res | 2014 | https://conductscience.org/library/papers/25436920 | PubMed |
| 18 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 19 | 32315233 | Breast Cancer in Young Women Presents With More Aggressive Pathologic Characteristics: Retrospective Analysis From an Argentine National Database. | JCO Glob Oncol | 2020 | https://conductscience.org/library/papers/32315233 | PubMed |
| 20 | 22554997 | The effect of age on delay in diagnosis and stage of breast cancer. | Oncologist | 2012 | https://conductscience.org/library/papers/22554997 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41877752
GET https://conductscience.org/api/papers/v1/41877752/references?page=2